EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of growth hormone and thyrotropin secretion by somatostatin system in rat brain


Neuroendocrinology 42(3): 218-225
Regulation of growth hormone and thyrotropin secretion by somatostatin system in rat brain
Somatostatin inhibits growth hormone (GH) and thyrotropin (TSH) secretion in the rat. Previous studies have shown that small discrete lesions of the periventricular hypothalamic (PV) and medial basal amygdaloid (AMG) nuclei, which contain high concentrations of somatostatin neurons, reduce somatostatin-like immunoreactivity (SLI) in the median eminence (ME) by approximately two thirds and one third, respectively. The present study assessed the function of the PV and AMG somatostatin systems in the regulation of basal episodic GH and TSH secretion. Three experiments were performed in freely behaving, chronically cannulated adult male rats. In experiment 1, bilateral electrolytic lesions (20 mC) were placed in the PV at the level of the paraventricular nucleus. In experiment 2, bilateral thermal lesions (55.degree. C .times. 1 min) were placed in the AMG. In experiment 3, thermal lesions were placed in both the PV and AMG (PV/AMG). Blood samples were removed from animals every 15 min for 5.5 h 14-21 days postoperatively. The ME was microdissected for determination of SLI content. PV, AMG and PV/ASMG lesions reduced ME SLI by 59, 26, and 91%, respectively. PV or AMG lesions had no effect on the amplitude or frequency of GH secretory peaks, GH trough levels or the total amount of GH secreted, whereas combined PV/AMG lesions reduced GH peak levels. Lesions of the AMG caused a 34% increase in mean plasma TSH levels, while PV or PV/AMG lesions reduced TSH. The latter effect was probably caused by damage to thyrotropin-releasing hormone neurons and/or axons, which are also located in the PV region. These results suggest that (1) PV and AMG somatostain systems may not have a significant role in the regulation of basal episodic GH secretion and (2) the putative AMG somatostain system exerts a significant inhibitory influence on TSH secretion.


Accession: 006288288

PMID: 2869424



Related references

Regulation of growth hormone and thyrotropin secretion by somatostatin systems in rat brain. Neuroendocrinology 42(3): 218-225, 1986

Physiological role of thyrotropin releasing hormone and somatostatin in the control of thyrotropin and growth hormone secretion in the neo natal rats. Acta Endocrinologica Supplementum (225): 229, 1979

Effect of lesions in the periventricular nucleus of the preoptic-anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin. Brain Research 222(2): 267-276, 1981

Effects of lesions in the peri ventricular nucleus of the preoptic anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin. Brain Research 222(2): 267-276, 1981

Growth hormone secretion from chicken adenohypophyseal cells in primary culture: effects of human pancreatic growth hormone-releasing factor, thyrotropin-releasing hormone, and somatostatin on growth hormone release. General and Comparative Endocrinology 65(3): 408-414, 1987

Growth hormone secretion from chicken adenohypophyseal cells in primary culture effects of human pancreatic growth hormone releasing factor thyrotropin releasing hormone and somatostatin on growth hormone release. General & Comparative Endocrinology 65(3): 408-414, 1987

The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man. Journal of Clinical Endocrinology and Metabolism 69(4): 906-909, 1989

Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3'-triiodothyronine and dexamethasone on thyrotropin secretion. Journal of Endocrinological Investigation 7(4): 313-317, 1984

Thyrotropin-releasing hormone stimulation and somatostatin inhibition of growth hormone secretion from perfused rat adenohypophyses. Endocrinology 94(6): 1709-1713, 1974

Somatostatin inhibition of thyrotropin-releasing hormone- and growth hormone-releasing factor-induced growth hormone secretion in young and adult anesthetized chickens. General and Comparative Endocrinology 75(2): 256-264, 1989